During the past decade, Hospital Arquitecto Marcide conducted 26 clinical trials. In the 10-year time frame, 26 clinical trials started and 6 clinical trials were completed, i.e. on average, 23.1% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 2 clinical trials were completed. i.e. 14.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Arquitecto Marcide" #1 sponsor was "Bayer" with 5 trials, followed by "Centro Nacional de Investigaciones Oncologicas CARLOS III" with 3 trials sponsored, "Pfizer" with 3 trials sponsored, "Eli Lilly and Company" with 2 trials sponsored and "Galapagos NV" with 2 trials sponsored. Other sponsors include 19 different institutions and companies that sponsored additional 25 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Arquitecto Marcide" #1 collaborator was "Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud" with 2 trials as a collaborator, "Gilead Sciences" with 2 trials as a collaborator, "Anavex Germany GmbH" with 1 trials as a collaborator, "Complexo Hospitalario Universitario de A Coruña" with 1 trials as a collaborator and "Effice Servicios Para la Investigacion S.L." with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Arquitecto Marcide" are "Advanced Prostate Cancer" (3 trials), "Crohn's Disease" (3 trials), "Cardiovascular Disease" (2 trials), "Castration Resistant" (2 trials) and "Chronic Kidney Disease" (2 trials). Many other conditions were trialed in "Hospital Arquitecto Marcide" in a lesser frequency.

Most popular intervention types in "Hospital Arquitecto Marcide" are "Drug" (28 trials), "Device" (2 trials), "Other" (2 trials), "Biological" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "Filgotinib" (2 trials), "bococizumab (PF-04950615)" (2 trials), "Adalimumab" (1 trials) and "Apalutamide" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Arquitecto Marcide" are 30 trials for "All" genders, 6 trials for "Male" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Hospital Arquitecto Marcide". undefined are not yet recruiting, 11 are recruiting, 2 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 18 completed trials in Hospital Arquitecto Marcide, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Arquitecto Marcide, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 0 trials that are defined as “Not Applicable".